David C. Grimsditch

400 total citations
16 papers, 315 citations indexed

About

David C. Grimsditch is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, David C. Grimsditch has authored 16 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Immunology and 4 papers in Surgery. Recurrent topics in David C. Grimsditch's work include Chemokine receptors and signaling (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cholesterol and Lipid Metabolism (3 papers). David C. Grimsditch is often cited by papers focused on Chemokine receptors and signaling (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cholesterol and Lipid Metabolism (3 papers). David C. Grimsditch collaborates with scholars based in United Kingdom, United States and India. David C. Grimsditch's co-authors include G. Martin Benson, Sheng Yun, Vinay K. Bhatia, Marina Botto, Joseph J. Boyle, Dorian O. Haskard, Martin Vidgeon-Hart, Pieter H.E. Groot, Philip Overend and Sally A. Penfold and has published in prestigious journals such as Arteriosclerosis Thrombosis and Vascular Biology, American Journal Of Pathology and British Journal of Pharmacology.

In The Last Decade

David C. Grimsditch

16 papers receiving 307 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David C. Grimsditch United Kingdom 10 147 110 58 51 41 16 315
Yogita Kashyap United Kingdom 2 135 0.9× 100 0.9× 54 0.9× 30 0.6× 71 1.7× 4 561
Charles N. Serhan United States 7 179 1.2× 174 1.6× 119 2.1× 68 1.3× 26 0.6× 7 577
Guillermo Sanjuán Spain 8 244 1.7× 160 1.5× 29 0.5× 37 0.7× 47 1.1× 8 476
Eva Sánchez-Galán Spain 7 119 0.8× 132 1.2× 42 0.7× 85 1.7× 48 1.2× 9 408
Dae‐Weon Park South Korea 13 153 1.0× 172 1.6× 33 0.6× 34 0.7× 46 1.1× 16 371
Kevin Yang United States 8 131 0.9× 199 1.8× 32 0.6× 37 0.7× 36 0.9× 12 420
Aurore Devocelle France 12 149 1.0× 134 1.2× 29 0.5× 46 0.9× 31 0.8× 15 488
Yoichiro Takami Japan 13 58 0.4× 178 1.6× 32 0.6× 39 0.8× 65 1.6× 25 385
Helen Galczenski United States 9 113 0.8× 171 1.6× 187 3.2× 104 2.0× 19 0.5× 9 438
D. Hamish Wright United States 8 45 0.3× 103 0.9× 120 2.1× 36 0.7× 29 0.7× 15 344

Countries citing papers authored by David C. Grimsditch

Since Specialization
Citations

This map shows the geographic impact of David C. Grimsditch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David C. Grimsditch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David C. Grimsditch more than expected).

Fields of papers citing papers by David C. Grimsditch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David C. Grimsditch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David C. Grimsditch. The network helps show where David C. Grimsditch may publish in the future.

Co-authorship network of co-authors of David C. Grimsditch

This figure shows the co-authorship network connecting the top 25 collaborators of David C. Grimsditch. A scholar is included among the top collaborators of David C. Grimsditch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David C. Grimsditch. David C. Grimsditch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Cheng, Kian-Kai, G. Martin Benson, David C. Grimsditch, et al.. (2010). Metabolomic study of the LDL receptor null mouse fed a high-fat diet reveals profound perturbations in choline metabolism that are shared with ApoE null mice. Physiological Genomics. 41(3). 224–231. 32 indexed citations
2.
Bhatia, Vinay K., Sheng Yun, David C. Grimsditch, et al.. (2007). Complement C1q Reduces Early Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice. American Journal Of Pathology. 170(1). 416–426. 127 indexed citations
4.
Hegyi, László, Paul Hockings, G. Martin Benson, et al.. (2004). Short term arterial remodelling in the aortae of cholesterol fed New Zealand white rabbits shown in vivo by high-resolution magnetic resonance imaging — implications for human pathology. Pathology & Oncology Research. 10(3). 159–165. 9 indexed citations
6.
McAteer, Martina A., David C. Grimsditch, Martin Vidgeon-Hart, G. Martin Benson, & Andrew M. Salter. (2003). Dietary cholesterol reduces lipoprotein lipase activity in the atherosclerosis-susceptible Bio F1B hamster. British Journal Of Nutrition. 89(3). 341–350. 12 indexed citations
7.
Murphy, Nuala, K. Richard Bruckdorfer, David C. Grimsditch, et al.. (2003). Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden Mice. Arteriosclerosis Thrombosis and Vascular Biology. 23(9). 1615–1620. 14 indexed citations
8.
Murphy, Nuala, David C. Grimsditch, Martin Vidgeon-Hart, et al.. (2002). Hypercholesterolaemia and circulating levels of CXC chemokines in apoE*3 Leiden mice. Atherosclerosis. 163(1). 69–77. 7 indexed citations
9.
Grimsditch, David C., Sally A. Penfold, Judy Latcham, et al.. (2000). C3H apoE(−/−) mice have less atherosclerosis than C57BL apoE(−/−) mice despite having a more atherogenic serum lipid profile. Atherosclerosis. 151(2). 389–397. 32 indexed citations
10.
Benson, G. Martin, David C. Grimsditch, Kitty Moores, et al.. (2000). Anti-atherosclerotic effect of SB-244323, a lipoprotein associated phospholipase A2 inhibitor, in WHHL rabbits. Atherosclerosis. 151(1). 166–166. 12 indexed citations
11.
Benson, G. Martin, David C. Grimsditch, John G. Phillips, & Keith E. Suckling. (1997). 1.P.96 Plasma lipids and atherosclerosis in froxfield mixed hyperlipidaemic (previously St Thomas Hospital) rabbits. Atherosclerosis. 134(1-2). 36–37. 2 indexed citations
12.
Grimsditch, David C., et al.. (1997). 1.P.94 Characterisation of lipoprotein metabolism in the froxfield mixed hyperlipidaemic rabbit. Atherosclerosis. 134(1-2). 36–36. 3 indexed citations
13.
Mainwaring, Scott, et al.. (1996). La construccion de instituciones democraticas : sistemas de partidos en América Latina. Medical Entomology and Zoology. 7 indexed citations
14.
Turner, Nicholas C., David C. Grimsditch, Janine A. Lamb, et al.. (1994). Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea‐pig. British Journal of Pharmacology. 111(4). 1198–1204. 4 indexed citations
15.
Murray, Kenneth, David C. Grimsditch, Bella Patel, et al.. (1992). The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function. British Journal of Pharmacology. 107(2). 463–470. 20 indexed citations
16.
Murray, Kenneth, P. England, David C. Grimsditch, et al.. (1991). Potential use of selective phosphodiesterase inhibitors in the treatment of asthma.. PubMed. 34. 27–46. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026